Credit: Dexcom. The Dexcom G7 15 Day CGM system ... scanning required. The sensor was evaluated in a study that included 130 adults aged 18 years and older with type 1 or type 2 diabetes.

The FDA has cleared the Dexcom G7 15 Day for adults with type 1 and ... with less sensor changes. The extended wear time of 15 days is similar to the Abbott FreeStyle Libre 2+ and Libre 3 ...

Along those lines, I'm excited to share that as of this summer, the third major PBM will also begin covering Dexcom G7 for anyone with diabetes in some of their key formularies. Having the 3 ...

Dexcom has begun to make progress in penetrating the Type 2 market, in addition to long dominating the Type 1 market ... US regulatory approval of the G7 15-day sensor, and the offsetting pressure ...

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship G7 sensor. The new system, which boosts wear time up from the previous ...

I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...

Discover Dexcom's Q1 2025 earnings highlights, including 14% revenue growth, expanded type 2 diabetes coverage, and the upcoming launch of the 15-day ...

“The approval of Dexcom G7 15 Day marks another major innovation for Dexcom,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “By listening to the needs of ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 ... 1 Dexcom, Data on File, 2025. 2 Dexcom, Data on File, 2023. 3 Garg ...

The tech-heavy Nasdaq led the rally among all major indices, finishing up by 1.51 percent ... our product portfolio with the launch of our Dexcom G7 15-Day system and continue to advocate for ...

Continuous glucose meters (CGMs) aren’t just widgets for the wellness crowd. For many, CGMs are real-time feedback machines for the body, offering glucose trendlines that help people rethink ...